- Home
- ESYN vs MDCX Comparison
ESYN vs MDCX Comparison
Compare ESYN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESYN | MDCX |
|---|---|---|
| Founded | 2021 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 10.9M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ESYN | MDCX |
|---|---|---|
| Price | $1.37 | $1.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $171.67 |
| AVG Volume (30 Days) | 4.5K | ★ 60.9K |
| Earning Date | 10-22-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.37 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $866,926.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.32 | $1.63 |
| 52 Week High | $2.68 | $127.50 |
Technical Indicators
Market Signals| Indicator | ESYN | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 21.18 |
| Support Level | N/A | N/A |
| Resistance Level | $1.85 | $8.55 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 25.93 | 9.44 |
Price Performance
Historical ComparisonAbout ESYN EnerSyn Global Inc. Common Stock
EnerSyn Global Inc, formerly HWH International Inc and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore. The Company is presently developing Hapi Marketplace, a business-to-consumer platform featuring diverse product categories, and Hapi Wealth Builder, an educational program focused on wealth-building strategies.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.